NASDAQ:BLUE
bluebird bio Stock News
$0.90
-0.0387 (-4.12%)
At Close: May 29, 2024
bluebird bio Reports Second Quarter 2020 Financial Results and Recent Operational Progress
08:10pm, Wednesday, 05'th Aug 2020
bluebird bio, Inc. (NASDAQ: BLUE) today reported financial results and business highlights for the second quarter ended June 30, 2020 and shared recent operational progress.
Why Earnings Season Could Be Great for bluebird bio (BLUE)
12:41pm, Wednesday, 05'th Aug 2020
bluebird bio (BLUE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Global Hematopoietic Stem Cells Transplantation (HSCT) Market will grow by USD 4.64 bn during 2020-2024
bluebird bio Announces August Investor Event
12:00pm, Friday, 31'st Jul 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced members of the management team will participate in the Canaccord Genuity 40th Annual Growth Conference, Wednesday, August 12, at 10:30 a.m. ET.
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:33pm, Thursday, 30'th Jul 2020
Bluebird (BLUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BMS and bluebird bio Announce Submission of Biologics License Application (BLA) to FDA for Idecabtagene Vicleucel (Ide-cel, bb2121)...
Gene Therapy Companies Are Racing to Cure Sickle Cell. That Would Open the Door to Curing Dozens of Other Diseases.
03:52pm, Saturday, 25'th Jul 2020
Successful treatments would demonstrate the potential for gene therapy—and boost a number of biotech companies.
Were Hedge Funds Right About bluebird bio Inc (BLUE)?
05:41pm, Monday, 13'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
How Much Of bluebird bio, Inc. (NASDAQ:BLUE) Do Institutions Own?
04:08pm, Tuesday, 07'th Jul 2020
The big shareholder groups in bluebird bio, Inc. (NASDAQ:BLUE) have power over the company. Insiders often own a large...
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer
12:00am, Thursday, 02'nd Jul 2020
Rexgenero, a regenerative medicine company appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer.
Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake
12:31pm, Wednesday, 01'st Jul 2020
For instance, Shopify (NYSE: SHOP) has been an expensive stock for years. StoneCo (NASDAQ: STNE) has unbelievably good numbers. In my mind, StoneCo is very similar to Square (NYSE: SQ), the fintech
2 Top Gene-Editing Stocks to Buy Right Now | The Motley Fool
11:36am, Sunday, 28'th Jun 2020
Both of these biotech companies recently released encouraging data from clinical trials.
Two Sigma Advisers LP Decreases Holdings in bluebird bio Inc (NASDAQ:BLUE)
06:49am, Thursday, 25'th Jun 2020
Two Sigma Advisers LP trimmed its holdings in shares of bluebird bio Inc (NASDAQ:BLUE) by 0.4% in the first quarter, Holdings Channel reports. The firm owned 112,100 shares of the biotechnology compan
Global CAR T Cell Therapy Market to 2026 - by Regions, Targeted Antigens, Clinical Trials/Study & Companies - ResearchAndMarkets.com
12:00am, Wednesday, 24'th Jun 2020
The
How bluebird bio (BLUE) Stock Stands Out in a Strong Industry
12:39pm, Tuesday, 23'rd Jun 2020
bluebird bio (BLUE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
